December 2022
Healius anoints new CEO on $4m pay package
The medical testing company confirms Malcolm Parmenter is stepping down after five years.
- Liam Walsh and Carrie LaFrenz
- Exclusive
- Executive shake-up
Healius CEO poised to step down next year
After five tough years at the helm of the pathology and imaging player, Dr Malcolm Parmenter plans to retire next year.
- Updated
- Carrie LaFrenz
Healius CEO Malcolm Parmenter sells shares, misses consensus
It was a lovely piece of timing from the boss.
- Joe Aston
October 2021
Surging COVID-19 testing boosts Healius’ first-quarter sales
The pathology player posted a 44 per cent jump in group revenue driven by COVID-19 testing and stronger than expected routine testing.
- Carrie LaFrenz
August 2021
COVID-19 testing surge will boost Healius earnings: Macquarie
The pathology company has gained from more COVID-19 tests, but routine medical tests have likely fallen amid lockdowns.
- Carrie LaFrenz
May 2021
Healius flags possible sale of its IVF business
News of the possible divestment came as the company delivered a strong performance in the third quarter of fiscal 2021.
- Carrie LaFrenz
February 2021
Healius repays $1.3m in JobKeeper, doubles dividend
The $2.5 billion healthcare company said robust testing volumes continued in the current half.
- Updated
- Carrie LaFrenz